Literature DB >> 11777520

Effect of antenatal and postnatal corticosteroid therapy on weight gain and head circumference growth in the nursery.

James A Thorp1, Philip G Jones, Joyce L Peabody, Eric Knox, Reese H Clark.   

Abstract

OBJECTIVE: To assess the effect of antenatal and postnatal corticosteroids on head circumference growth and weight gain from birth to discharge.
METHODS: We conducted a retrospective analysis of nonanomalous newborns admitted to the neonatal intensive care unit from 23 to 34 6/7 weeks of gestation. Independent variables included maternal age, race, nulliparity, poor prenatal care, multiple gestation, obstetric complications, alcohol, tocolytic drugs, smoking, illicit drugs, gestational age at birth, presentation, method of delivery, 5-minute Apgar score < 7, surfactant use, severe intracranial hemorrhage, and length of stay.
RESULTS: Antenatal and postnatal corticosteroids were given in 62% and 14% of the newborns, respectively, and 10% of newborns received both. The mean (+/-SD) weight gain and head circumference growth in the nursery was 440 +/- 582 g (n = 14,217) and 2.54 +/- 3.42 cm (n = 12,808), respectively. After multivariable analysis, use of antenatal corticosteroids did not affect weight gain (3.6 +/- 4.6 g) and head circumference growth (0.05 +/- 0.04 cm) compared with no exposure to perinatal corticosteroids, but postnatal corticosteroids were associated with significant reductions in weight gain and head circumference growth (-120 +/- 12.2 g and -0.53 +/- 0.11 cm, respectively).
CONCLUSIONS: Antenatal corticosteroid therapy did not affect weight gain or head circumference growth in the nursery, even when used in conjunction with postnatal corticosteroid therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11777520     DOI: 10.1016/s0029-7844(01)01657-x

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  Repeat lumbar punctures in infants with meningitis in the neonatal intensive care unit.

Authors:  R G Greenberg; D K Benjamin; M Cohen-Wolkowiez; R H Clark; C M Cotten; M Laughon; P B Smith
Journal:  J Perinatol       Date:  2010-12-16       Impact factor: 2.521

2.  Gestational age-specific risks vs benefits of multicourse antenatal corticosteroids for preterm labor.

Authors:  Laurie C Zephyrin; Kimberly N Hong; Ronald J Wapner; Alan M Peaceman; Yoram Sorokin; Donald J Dudley; Jay D Iams; Margaret Harper; Steve N Caritis; Brian M Mercer; John M Thorp; Susan M Ramin; Dwight J Rouse; Baha Sibai
Journal:  Am J Obstet Gynecol       Date:  2013-06-13       Impact factor: 8.661

3.  Association of Adverse Hearing, Growth, and Discharge Age Outcomes With Postnatal Cytomegalovirus Infection in Infants With Very Low Birth Weight.

Authors:  Kristin E D Weimer; Matthew S Kelly; Sallie R Permar; Reese H Clark; Rachel G Greenberg
Journal:  JAMA Pediatr       Date:  2020-02-01       Impact factor: 16.193

4.  Oxidative stress in the developing brain: effects of postnatal glucocorticoid therapy and antioxidants in the rat.

Authors:  Emily J Camm; Deodata Tijsseling; Hans G Richter; Alexandra Adler; Jeremy A Hansell; Jan B Derks; Christine M Cross; Dino A Giussani
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

5.  Single-course antenatal corticosteroids is related to faster growth in very-low-birth-weight infant.

Authors:  Jiajia Jing; Yiheng Dai; Yanqi Li; Ping Zhou; Xiaodong Li; Jiaping Mei; Chunyi Zhang; Per Trop Sangild; Zhaoxie Tang; Suhua Xu; Yanbin Su; Xiaoying He; Yanna Zhu
Journal:  BMC Pregnancy Childbirth       Date:  2021-01-12       Impact factor: 3.007

6.  Postnatal Cytomegalovirus Infection and the Risk for Bronchopulmonary Dysplasia.

Authors:  Matthew S Kelly; Daniel K Benjamin; Karen M Puopolo; Matthew M Laughon; Reese H Clark; Sagori Mukhopadhyay; Daniel K Benjamin; P Brian Smith; Sallie R Permar
Journal:  JAMA Pediatr       Date:  2015-12-07       Impact factor: 26.796

7.  Incidence of Breakthrough Urinary Tract Infection in Hospitalized Infants Receiving Antibiotic Prophylaxis.

Authors:  Jessica C Lloyd; Christoph P Hornik; Daniel K Benjamin; Reese H Clark; Jonathan C Routh; P Brian Smith
Journal:  Clin Pediatr (Phila)       Date:  2016-07-19       Impact factor: 1.701

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.